INTRODUCTION
Epstein-Barr virus (EBV) is a ubiquitous gammaherpesvirus, which is causatively associated with the development of several human malignancies, including Burkitt's lymphomas and nasopharyngeal carcinoma (NPC) [1] . Following primary infection EBV establishes lifelong persistent infection [2] . EBV replication is under the control of some host and virus factors. Epstein-Barr virus nuclear antigen 1 (EBNA1) is the only viral protein expressed in all types of tumors, and it is essential for the replication and mitotic segregation of EBV episomes to daughter cells [3] . During the viral replication and segregation, EBV may interact with a series of host proteins [4] . Bimolecular complementation (BiMC) assay is a useful approach method for the detection, visualization and map of protein-protein interactions in live mammalian cells [5] . In this system, the enhanced yellow fluorescent protein (EYFP) is split into N-and Cterminal fragments, and reconstitution of these two fragments takes place by the mediation of a proteinprotein interaction, thus resulting in irreversible fluorescent signal [6] . In order to improve our understanding of the interaction patterns of EBNA1 and host proteins, in this study, we established a BiMC assay system expressing a fusion protein of EBNA1 and the C-termini of EYFP, and this system was employed in the assay for a interaction detection of EBNA1 with one host protein in living 293T cells.
MATERIALS AND METHODS

Cells, antibodies and plasmids
Human embryonic kidney cells (293T) and COS-7 were ATCC origin and maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal calf serum. Mouse monoclonal antibodies against c-MYC and EBNA1 were products from Sigma and Abcam companies respectively and used according to the manufacturer's instructions. The anti-β-actin antibody (Santa Cruz) was used as a loading control. Plasmid pCAGGS vector, the plasmid containing full-length Venus YFP and the plasmid pNYFP-X1 containing fused N-ternimal YFP and cellular X1 protein gene were kind gifts from Dr. Harty (University of Pennsylvania) [7] . All recombinant plasmids containing C-termini of YFP and EBNA1 gene were constructed by standard cloning techniques using the pCAGGS vector.
Western blotting
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Immuno-fluorescence assay
Immunofluorescence was performed for the detection of the expression of fused CYFP-EBNA1. Fresh COS-7 cells were seeded onto coverslips in wells of a six-well plate. At 24 hr post-transfection of the plasmids using the TurboFect Transfection Regeat (Thermo), the cells were treated with 0.25% triton X-100 and washed with PBS, then the first antibody was added and incubated for 1.5 hrs at room temperature. After three washes with PBS, the coveslips were incubated with the second antibodies, Alexa Fluo @ 488 monkey anti-rabbit IgG (H+L) (Life Technologies) for 1 h at room temperature and washed three times. Then they were treated with Hoechst (Beyotime Inc., China) for 10 min and washed. The coverslips were observed under a fluorecent microscope.
BiMC assay
Human 293T cells were grown on coverslips as described above. The pCAGGS-CYFP-EBNA1 and pCAGGS-NYFP-X1 plasmids were co-transfected into the cells. At 24 hr post-transfection, cells were washed twice with PBS and fixed with cold methanol-acetone (1:1, v/v) for 10 minutes at room temperature. Cells were washed and subsequently stained with Hoechst for 10 minutes at room temperature. Cells were washed and slides were viewed under a fluorescent microscope.
RESULTS AND DISCUSSION
Construction of plasmid pCAGGS-CYFP-EBNA1
The basic strategy of BiMC is illustrated in Figure 1 . The C-terminal of EYFP was firstly cloned into pCAGGS vector, resulting in a plasmid designated pCAAGS-CYFP. EBNA1 gene was also PCRamplified from the EBV B95.8 strain. A c-myc tag at the N-terminal was introduced by the forward primer, and was cloned into pCAGGS-CYFP, resulting in a fused CYFP-cMyc-EBNA1 expression box. The expression plasmid was identified by using restriction enzymes according to the design and sent for being sequenced, and the result showed that the plasmid was successfully constructed.
Expression of EBNA1 detected by western blotting assay
In order to make sure that the expression plasmid was able to express fused CYFP-cMYC-EBNA1 as expected, the plasmid was transfected into 293T cells which is EBV negative, at 24 hr posttransfection, the general cellular protein was extracted and subject to a western-blotting assay. As Figure 2 showed, both anti-cMyc and anti-EBNA1 antibodies could detect the expression of the expected fusion protein with an expected size of about 70kD. Figure 2 The detection of fused CYFP-MYC-EBNA1 by western blotting
Localization of CYFP-EBNA1 in living cells
EBNA1 is important for the replication and mitotic segregation of EBV episomes, and usually expressed in cellular nuclear. Here, immunofluorescence assay, in which anti-cMyc antibody was used as specific antibody, was employed to detect if fused CYFP-EBNA1 also localization in the nuclear of COS-7 cells. As it was shown in Figure 3 , the fusion protein CYFP-cMYC-EBNA1could localize in the nuclear, with the minority being expressed in cytoplasm.
Interaction assay of EBNA1 and host protein by BiMC
Some host proteins were reported to interact with EBNA1 during the replication and segregation of EBV episomes. In this study, we tried one since we speculated it may also be involved in the interaction. The result also showed that the interaction took place in the nuclear (Figure 4 ). In conclusion, we have successfully established the BiMC assay system for the interaction detection of EBNA1 with host proteins. BiMC approach is useful for detecting and recording transient interaction events, allowing for detection of shortlived and weak protein-protein interactions in intact living cells. The outstanding advantage of this assay is that it enables characterization of protein-protein interactions in the natural cellular environment [5] [6] [7] . The establishment of this system in the present study would largely help us to understand the interaction pattern of EBNA1 with host proteins, and provided the feasibility of using the BiMC approach for our further understanding about the roles of EBNA1.
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